ABL vs. ML, PAX, BSIG, BRDG, FDUS, NOAH, VINP, ALTI, BBDC, and DHIL
Should you be buying Abacus Life stock or one of its competitors? The main competitors of Abacus Life include MoneyLion (ML), Patria Investments (PAX), BrightSphere Investment Group (BSIG), Bridge Investment Group (BRDG), Fidus Investment (FDUS), Noah (NOAH), Vinci Partners Investments (VINP), AlTi Global (ALTI), Barings BDC (BBDC), and Diamond Hill Investment Group (DHIL).
MoneyLion (NYSE:ML) and Abacus Life (NASDAQ:ABL) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings, analyst recommendations and community ranking.
In the previous week, MoneyLion had 4 more articles in the media than Abacus Life. MarketBeat recorded 11 mentions for MoneyLion and 7 mentions for Abacus Life. MoneyLion's average media sentiment score of 0.74 beat Abacus Life's score of 0.65 indicating that Abacus Life is being referred to more favorably in the news media.
Abacus Life has lower revenue, but higher earnings than MoneyLion. MoneyLion is trading at a lower price-to-earnings ratio than Abacus Life, indicating that it is currently the more affordable of the two stocks.
Abacus Life has a net margin of 0.11% compared to Abacus Life's net margin of -6.42%. MoneyLion's return on equity of 4.97% beat Abacus Life's return on equity.
MoneyLion has a beta of 2.68, suggesting that its stock price is 168% more volatile than the S&P 500. Comparatively, Abacus Life has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500.
31.4% of MoneyLion shares are held by institutional investors. 14.1% of MoneyLion shares are held by insiders. Comparatively, 47.0% of Abacus Life shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
MoneyLion received 12 more outperform votes than Abacus Life when rated by MarketBeat users. Likewise, 70.59% of users gave MoneyLion an outperform vote while only 0.00% of users gave Abacus Life an outperform vote.
MoneyLion currently has a consensus price target of $78.60, suggesting a potential upside of 6.31%. Given Abacus Life's higher probable upside, analysts clearly believe MoneyLion is more favorable than Abacus Life.
Summary
Abacus Life beats MoneyLion on 9 of the 17 factors compared between the two stocks.
Get Abacus Life News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ABL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Abacus Life Competitors List
Related Companies and Tools
